AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
192.87
-0.58 (-0.30%)
Feb 14, 2025, 4:00 PM EST - Market closed
AbbVie Stock Forecast
Stock Price Forecast
The 20 analysts with 12-month price forecasts for AbbVie stock have an average target of 209.6, with a low estimate of 185 and a high estimate of 239. The average target predicts an increase of 8.67% from the current stock price of 192.87.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AbbVie stock from 21 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 8 | 9 | 8 | 8 | 8 |
Buy | 9 | 9 | 11 | 11 | 11 | 10 |
Hold | 2 | 3 | 2 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 15 | 20 | 22 | 22 | 22 | 21 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Citigroup | Citigroup | Strong Buy Maintains $205 → $215 | Strong Buy | Maintains | $205 → $215 | +11.47% | Feb 3, 2025 |
Truist Securities | Truist Securities | Strong Buy Maintains $211 → $217 | Strong Buy | Maintains | $211 → $217 | +12.51% | Feb 3, 2025 |
UBS | UBS | Hold Maintains $181 → $190 | Hold | Maintains | $181 → $190 | -1.49% | Feb 3, 2025 |
Wells Fargo | Wells Fargo | Buy Maintains $195 → $210 | Buy | Maintains | $195 → $210 | +8.88% | Feb 3, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $224 → $239 | Buy | Maintains | $224 → $239 | +23.92% | Feb 3, 2025 |
Financial Forecast
Revenue This Year
60.64B
from 56.33B
Increased by 7.64%
Revenue Next Year
65.35B
from 60.64B
Increased by 7.78%
EPS This Year
12.41
from 2.39
Increased by 419.32%
EPS Next Year
14.03
from 12.41
Increased by 13.03%
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 63.6B | 70.0B | 75.0B | ||
Avg | 60.6B | 65.4B | 69.9B | ||
Low | 57.2B | 60.5B | 64.2B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 12.9% | 15.4% | 14.7% | ||
Avg | 7.6% | 7.8% | 6.9% | ||
Low | 1.6% | -0.2% | -1.7% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 13.65 | 15.70 | 18.15 | ||
Avg | 12.41 | 14.03 | 15.33 | ||
Low | 11.30 | 12.81 | 13.60 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 471.0% | 26.5% | 29.4% | ||
Avg | 419.3% | 13.0% | 9.3% | ||
Low | 372.8% | 3.2% | -3.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.